National utilization of transdermal fentanyl among community-dwelling older people in Finland

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 6, 2009, Pages 355-361

  Simon Bell, J ^a   Klaukka, Timo ^b   Ahonen, Jouni ^a,c   Hartikainen, Sirpa ^a,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d Leppavirta Health Centre   (Finland)

Author keywords

aged; analgesics; drug utilization; fentanyl; Finland

Indexed keywords

FENTANYL; HYDROMORPHONE; MORPHINE; OXYCODONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; CULTURAL FACTOR; DRUG CHOICE; DRUG INDICATION; DRUG UTILIZATION; ELDERLY CARE; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REIMBURSEMENT; SEX DIFFERENCE;

ADMINISTRATION, CUTANEOUS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DRUG UTILIZATION; FEMALE; FENTANYL; FINLAND; HUMANS; MALE; MIDDLE AGED;

EID: 74949134364     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.11.006     Document Type: Article

References (34)

1. Brixner D.I., Oderda G.M., Roland C.L., and Rublee D.A. Opioid expenditures and utilization in the Medicaid system. J Pain Palliat Care Pharmacother. 20 (2006) 5-13
2. Hudec R., Tisonová J., Bozeková L., and Foltán V. Trends in consumption of opioid analgesics in the Slovak Republic during 1998-2002. Eur J Clin Pharmacol. 60 (2004) 445-448
3. Garcia del Pozo J., Carvajal A., Viloria J.M., et al. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 64 (2008) 411-415
4. Hamunen K., Paakkari P., and Kalso E. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain. 13 (2009) 954-962
5. Mercadante S. Opioid prescription in Italy: New law, no effect. Lancet. 360 (2002) 1254-1255
6. Auret K., and Schug S.A. Underutilisation of opioids in elderly patients with chronic pain: Approaches to correcting the problem. Drugs Aging. 22 (2005) 641-654
7. Nwokeji E.D., Rascati K.L., Brown C.M., and Eisenberg A. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clin Ther. 29 Theme Issue (2007) 2589-2602
8. McLachlan A.J., Hilmer S.N., and Le Couteur D.G. Variability in response to medicines in older people: Phenotypic and genotypic factors. Clin Pharmacol Ther. 85 (2009) 431-433
9. Pergolizzi J., Böger R.H., Budd K., et al. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8 (2008) 287-313
10. National Prescribing Service Limited (NPS). Fentanyl patches (Durogesic) for chronic pain. http://www.nps.org.au/health_professionals/publications/nps_radar/curren t/august_2006/fentanyl_patches Accessed November 11, 2009
11. Kalso E. Medical treatment of cancer pain [in Finnish]. http://www.terveysportti.fi/pls/kh/kh_julkaisu.NaytaArtikkeli?p_artikkel i=ykt00396 Accessed November 11, 2009
12. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 57 (2009) 1331-1346
13. Kalso E., Paakkari P., and Forsell M. Use of opioids for longterm pain [in Finnish]. National Agency for Medicines. http://www.nam.fi/instancedata/prime_product_julkaisu/laakelaitos/embeds /opioidit-opas.pdf Accessed November 11, 2009
14. Kalso E., Allan L., Dellemijn P.L., et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 7 (2003) 381-386
15. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 10 (2009) 113-130
16. Muijsers R.B., and Wagstaff A.J. Transdermal fentanyl: An updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 61 (2001) 2289-2307
17. United States Food and Drug Administration (FDA). Public Health Advisory. Fentanyl transdermal patch: Important information for the safe use of fentanyl transdermal system (patch). http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm048721.htm Accessed August 8, 2009
18. Saari T.I., Laine K., Neuvonen M., et al. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Eur J Clin Pharmacol. 64 (2008) 25-30
19. Rochon P.A., Stukel T.A., Bronskill S.E., et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 167 (2007) 676-683
20. Hughes C.M., Lapane K., Watson M.C., and Davies H.T. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 24 (2007) 81-93
21. National Agency for Medicines. Sales Statistics 2008. www.nam.fi Accessed August 8, 2009
22. Kornick C.A., Santiago-Palma J., Moryl N., et al. Benefitrisk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf. 26 (2003) 951-973
23. Wilder-Smith O.H. Opioid use in the elderly. Eur J Pain. 9 (2005) 137-140
24. Holdsworth M.T., Forman W.B., Killilea T.A., et al. Transdermal fentanyl disposition in elderly subjects. Gerontology. 40 (1994) 32-37
25. Leendertse A.J., Egberts A.C., Stoker L.J., van den Bemt P.M., and HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 168 (2008) 1890-1896
26. Nygaard H.A., Naik M., Ruths S., Straand J., and Bergen district nursing home (BEDNURS) study. Nursing-home residents and their drug use: A comparison between mentally intact and mentally impaired residents. Eur J Clin Pharmacol. 59 (2003) 463-469
27. Howard R.L., Avery A.J., Slavenburg S., et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 63 (2006) 136-147
28. Hamilton H.J., Gallagher P.F., and O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 9 (2009) 5
29. Dosa D.M., Dore D.D., Mor V., and Teno J.M. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. J Pain Symptom Manage. 38 (2009) 515-521
30. Rigler S.K., Shireman T.I., and Kallenbach L. Predictors of long-acting opioid use and oral versus transdermal route among older medicaid beneficiaries. Am J Geriatr Pharmacother. 5 (2007) 91-99
31. Kalso E. Opioid transdermal patches [in Finnish]. TABU. 6 (2008) 10-11. http://www.nam.fi/julkaisut/tabu/2008 Accessed November 11, 2009
32. National Agency for Medicines and Social Insurance Institution of Finland. Finnish Statistics on Medicines. www.nam.fi/medicines/drug_consumption/finnish_statistics_on_medicines Accessed November 11, 2009
33. Berger J.T. The influence of physicians' demographic characteristics and their patients' demographic characteristics on physician practice: Implications for education and research. Acad Med. 83 (2008) 100-105
34. Mercadante S. Opioid consumption in Italy: Industry is not necessarily business-look at the effects. J Pain Symptom Manage. 27 (2004) 391-392